Hims & Hers Health, Inc.

For the period ended Jun 30, 2026. Filed Aug 10, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 10, 2026

HIMS$22.94-11.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In Thousands, Except Share and Per Share Data)

	June 30, 2026	December 31, 2025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$609,811	$228,616
Short-term available-for-sale investments	231,237	348,876
Receivables, net	375,291	32,149
Inventory	87,781	80,128
Prepaid expenses and other current assets	80,493	77,869
Total current assets	1,384,613	767,638
Long-term available-for-sale investments	—	351,263
Goodwill	1,101,720	278,325
Property, equipment, and software, net	364,215	311,930
Intangible assets, net	422,809	196,116
Operating lease right-of-use assets	165,565	137,046
Deferred tax assets, net	111,578	82,707
Other long-term assets	78,314	29,680
Total assets	$3,628,814	$2,154,705
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$501,297	$143,278
Accrued liabilities	210,255	77,039
Deferred revenue	141,384	127,160
Deferred acquisition payable	537,381	1,479
Earn-out consideration	81,364	50,632
Operating lease liabilities	11,551	4,843
Total current liabilities	1,483,232	404,431
Convertible senior notes, net	1,365,299	972,580
Operating lease liabilities	169,389	143,167
Deferred acquisition payable	165,624	5,484
Earn-out consideration	81,600	53,009
Deferred tax liabilities, net	30,934	28,856
Other long-term liabilities	8,664	6,250
Total liabilities	3,304,742	1,613,777
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 224,920,310 and 218,867,898 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of June 30, 2026 and December 31, 2025	23	23
Additional paid-in capital	662,263	652,383
Accumulated other comprehensive (loss) income	(46,037)	2,294
Accumulated deficit	(292,177)	(113,772)
Total stockholders' equity	324,072	540,928
Total liabilities and stockholders' equity	$3,628,814	$2,154,705

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.